Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Epcoritamab and Rituximab for First-line Follicular Lymphoma

NCT05783609

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai Hospital New York, United States
  • University of Rochester Medical Center Rochester, New York, United States
View Trial Details
Recruiting

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

NCT07477587

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • D&H National Research Center Margate, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 81 locations
View Trial Details
Recruiting

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

NCT05676450

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

NCT06098430

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

NCT06911502

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Local Institution - 0225 Birmingham, Alabama, United States
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Local Institution - 0215 Little Rock, Arkansas, United States
View all 160 locations
View Trial Details

Related conditions